γ-Tocotrienol-Inhibited Cell Proliferation of Human Gastric Cancer by Regulation of Nuclear Factor-κB Activity

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Nuclear factor-κB (NF-κB) is a key regulator of cell proliferation, apoptosis, invasion, and migration in tumors.
• NF-κB plays a crucial role in pro-inflammatory responses and cancer development.
• Gamma-tocotrienol (γ-T3) is recognized for its anticancer properties, acting through modulation of cellular signaling pathways.

Purpose of the Study:

• To investigate the inhibitory effects of γ-T3 on NF-κB activity in gastric cancer cells.
• To elucidate the underlying molecular mechanisms by which γ-T3 exerts its anticancer effects.
• To explore the role of protein phosphatase 2A (PP2A) and ataxia-telangiectasia mutated (ATM) in γ-T3-mediated signaling.

Main Methods:

• Cell proliferation was assessed using MTT and methylene blue assays.
• NF-κB activity was measured using luciferase assays.
• PP2A activity, ATM phosphorylation, and protein expression were analyzed via ELISA and Western blotting.
• In vivo efficacy was evaluated in a BALB/c nude mouse model with human gastric cancer xenografts.

Main Results:

• γ-T3 significantly inhibited gastric cancer cell proliferation both in vitro and in vivo.
• γ-T3 treatment markedly attenuated NF-κB activity in gastric cancer cells.
• γ-T3 dramatically increased PP2A activity and protein expression, leading to suppressed ATM phosphorylation and cytoplasmic translocation.
• Tumor growth was significantly reduced in mice treated with γ-T3.

Conclusions:

• γ-T3 effectively inhibits gastric cancer cell proliferation and NF-κB activation through a PP2A-dependent mechanism.
• The findings suggest that γ-T3 modulates NF-κB signaling by enhancing PP2A activity, which in turn inhibits ATM phosphorylation.
• PP2A may represent a valuable molecular target for developing γ-T3 as a chemopreventive agent against gastric cancer.